NCT01313559 Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer Status TERMINATED Phase PHASE2
NCT01310166 Biomarker Study After Initiation of Treatment With Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis Status COMPLETED Phase PHASE4
NCT01309698 Drug Interaction of Vildagliptin (LAF237) With Voglibose in Japanese Patients With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT01305941 A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases Status COMPLETED Phase PHASE2
NCT01302899 To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy Status TERMINATED Phase PHASE2
NCT01302886 Study of BHQ880 in Patients With High Risk Smoldering Multiple Myeloma Status COMPLETED Phase PHASE2
NCT01302873 Study of BGG492 in Patients With Chronic Subjective Tinnitus Status COMPLETED Phase PHASE2
NCT01302860 Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease Status COMPLETED Phase PHASE3
NCT01300962 Study of BKM120 or BYL719 and Capecitabine in Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE1
NCT01300416 Measurement of Patient Reported Outcomes in Renal Transplant Patients With And Without Gastrointestinal (GI) Symptoms Status COMPLETED Phase N/A
NCT01299701 A Single Center Study to Characterize the Absorption, Distribution, Metabolism and Excretion (ADME) of ASA404 After a Single Infusion in Patients With Solid Tumors Status TERMINATED Phase PHASE1
NCT01299415 Safety and Pharmacokinetics of ASA404 When Given Together With Fluvoxamine, a Selective Serotonin Receptor Reuptake Inhibitor and CYP1A2 Inhibitor Status TERMINATED Phase PHASE1
NCT01297491 Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT01297452 BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01294826 Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT01294787 Effect of QVA149 on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE3
NCT01294774 Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus Status COMPLETED Phase PHASE2
NCT01294579 Ofatumumab and Bendamustine Followed by Maintenance Ofatumumab for Rituximab Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL) Status COMPLETED Phase PHASE2